Boston Scientific Elects David S. Wichmann To Board Of Directors

Rhea-AI Summary

Boston Scientific Corporation (NYSE: BSX) has announced the election of David S. Wichmann to its board of directors as of June 24, 2021. Wichmann previously served as the CEO of UnitedHealth Group from 2017 to 2021, with a career at the company spanning 23 years. His expertise includes enhancing patient outcomes and reducing healthcare costs. CEO Mike Mahoney expressed optimism about Wichmann's insights contributing to innovation at Boston Scientific. This move emphasizes the company's commitment to strengthening leadership that can drive growth and improve healthcare solutions.

Positive

• David Wichmann's extensive experience as CEO of UnitedHealth Group could bring valuable insights into healthcare improvements.
• Wichmann's background in financial management may enhance Boston Scientific's operational efficiencies.

Negative

• None.

MARLBOROUGH, Mass., June 24, 2021 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) announced today the election of David S. Wichmann to its board of directors, effective immediately.

Wichmann recently served as chief executive officer of UnitedHealth Group from 2017 to 2021. His career at UnitedHealth Group spans 23 years in roles of increasing responsibility leading the growth, diversification and performance of the company's domestic and international businesses, including president, chief financial officer, and head of operations and commercial markets. Prior to joining UnitedHealth Group, Wichmann was a partner at the global accounting firm Arthur Andersen & Co. He has served on the boards of UnitedHealth Group Incorporated and Tennant Company and holds a B.S. in accounting from Illinois State University.

"From his experience leading one of the largest health care organizations in the world, Dave has unique insights about opportunities to improve patient outcomes while also taking costs out of the health care system," said Mike Mahoney, chief executive officer and chairman of the board, Boston Scientific. "We welcome him to our board and look forward to working together to continue to deliver meaningful innovation to patients and health care providers."

About Boston Scientific

Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world.  As a global medical technology leader for more than 40 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare. For more information, visit www.bostonscientific.com and connect on Twitter and Facebook.

CONTACT:
Media:	Kate Haranis		Investors:	Lauren Tengler
	508-683-6585 (office)			508-683-4479 (office)
	Media Relations			Investor Relations
	Boston Scientific Corporation			Boston Scientific Corporation
	kate.haranis@bsci.com			BSXInvestorRelations@bsci.com

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/boston-scientific-elects-david-s-wichmann-to-board-of-directors-301319821.html

SOURCE Boston Scientific Corporation

FAQ

Who is David S. Wichmann in Boston Scientific's recent board election?

David S. Wichmann has been elected to the board of directors of Boston Scientific effective June 24, 2021. He is the former CEO of UnitedHealth Group.

What experience does David S. Wichmann bring to Boston Scientific?

Wichmann has over 23 years of experience at UnitedHealth Group, including roles as CEO, CFO, and head of operations, focusing on improving patient outcomes and reducing healthcare costs.

What impact might Wichmann's appointment have on Boston Scientific's strategy?

Wichmann's expertise in healthcare operations and financial management may provide fresh perspectives to enhance Boston Scientific's innovation and growth.